Literature DB >> 10340042

Risk factors for severe radiation pneumonitis in lung cancer.

T Makimoto1, S Tsuchiya, K Hayakawa, R Saitoh, M Mori.   

Abstract

BACKGROUND: Risk factors for severe radiation pneumonitis, which often spreads beyond treatment portals and may even be bilateral, have not been fully investigated. The purpose of this study was to identify important factors associated with severe radiation pneumonitis.
METHODS: 111 cases of primary lung cancer, treated with radiotherapy or chemoradiotherapy, were retrospectively analyzed.
RESULTS: Severe radiation pneumonitis occurred in 17 cases (15.3%). The ratio of interstitial change in lungs before radiotherapy and radiotherapy to the contralateral mediastinum with > 40 Gy in the radiation pneumonitis group (RP group) was significantly higher than in patients without radiation pneumonitis (control group) (47.1% vs 5.3%; P < 0.001 and 58.8% vs 27.7%; P = 0.037, respectively). Using logistic regression analysis, interstitial changes before radiotherapy and radiotherapy to the contralateral mediastinum of > 40 Gy were significant risk factors associated with severe radiation pneumonitis.
CONCLUSIONS: These data suggest that pre-existing interstitial changes detected by chest radiography or computed tomography and radiotherapy to the contralateral mediastinum (> 40 Gy) may predict the development of severe radiation pneumonitis.

Entities:  

Mesh:

Year:  1999        PMID: 10340042     DOI: 10.1093/jjco/29.4.192

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  17 in total

Review 1.  Prediction of radiation pneumonitis in lung cancer patients: a systematic review.

Authors:  Xiao-Jing Zhang; Jian-Guo Sun; Jie Sun; Hua Ming; Xin-Xin Wang; Lei Wu; Zheng-Tang Chen
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-29       Impact factor: 4.553

2.  Pre-Radiation Therapy Fluorine 18 Fluorodeoxyglucose PET Helps Identify Patients with Esophageal Cancer at High Risk for Radiation Pneumonitis.

Authors:  Richard Castillo; Ngoc Pham; Edward Castillo; Samantha Aso-Gonzalez; Sobiya Ansari; Brian Hobbs; Diana Palacio; Heath Skinner; Thomas M Guerrero
Journal:  Radiology       Date:  2015-01-13       Impact factor: 11.105

3.  Avascular necrosis of bilateral femoral head as a result of long-term steroid administration for radiation pneumonitis after tangential irradiation of the breast.

Authors:  Yasuhiro Kosaka; Michihide Mitsumori; Norio Araki; Chikako Yamauchi; Yasushi Nagata; Masahiro Hiraoka; Hiroshi Kodama
Journal:  Int J Clin Oncol       Date:  2006-12-25       Impact factor: 3.402

4.  Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.

Authors:  Ming Yin; Zhongxing Liao; Zhensheng Liu; Li-E Wang; Daniel Gomez; Ritsuko Komaki; Qingyi Wei
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-21       Impact factor: 7.038

5.  Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer.

Authors:  Cem H Misirlioglu; Taciser Demirkasimoglu; Bulent Kucukplakci; Ergun Sanri; Kadri Altundag
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

6.  Interstitial Lung Change in Pre-radiation Therapy Computed Tomography Is a Risk Factor for Severe Radiation Pneumonitis.

Authors:  Yun Hee Lee; Yeon Sil Kim; Sang Nam Lee; Hyo Chun Lee; Se Jin Oh; Seoung Joon Kim; Young Kyoon Kim; Dae Hee Han; Ie Ryung Yoo; Jin Hyung Kang; Suk Hee Hong
Journal:  Cancer Res Treat       Date:  2015-02-13       Impact factor: 4.679

7.  Impact of Preexisting Interstitial Lung Disease on Acute, Extensive Radiation Pneumonitis: Retrospective Analysis of Patients with Lung Cancer.

Authors:  Yuichi Ozawa; Takefumi Abe; Minako Omae; Takashi Matsui; Masato Kato; Hirotsugu Hasegawa; Yasunori Enomoto; Takeaki Ishihara; Naoki Inui; Kazunari Yamada; Koshi Yokomura; Takafumi Suda
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

8.  PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial.

Authors:  Sebastian Zschaeck; Monique Simon; Steffen Löck; Esther G C Troost; Kristin Stützer; Patrick Wohlfahrt; Steffen Appold; Sebastian Makocki; Rebecca Bütof; Christian Richter; Michael Baumann; Mechthild Krause
Journal:  Trials       Date:  2016-11-15       Impact factor: 2.279

9.  The effects of radiation and dose-fractionation on cancer and non-tumor disease development.

Authors:  William Liu; Benjamin M Haley; Mary J Kwasny; Jian-Jian Li; David J Grdina; Tatjana Paunesku; Gayle E Woloschak
Journal:  Int J Environ Res Public Health       Date:  2012-12-18       Impact factor: 3.390

10.  Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer.

Authors:  Richard Castillo; Ngoc Pham; Sobiya Ansari; Dmitriy Meshkov; Sarah Castillo; Min Li; Adenike Olanrewaju; Brian Hobbs; Edward Castillo; Thomas Guerrero
Journal:  Radiat Oncol       Date:  2014-03-13       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.